These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 8736266)

  • 1. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
    Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
    Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity.
    Maccario M; Procopio M; Grottoli S; Oleandri SE; Boffano GM; Taliano M; Camanni F; Ghigo E
    Metabolism; 1996 Mar; 45(3):342-6. PubMed ID: 8606641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.
    Broglio F; Benso A; Gottero C; Vito LD; Aimaretti G; Fubini A; Arvat E; Bobbio M; Ghigo E
    Eur J Endocrinol; 2000 Feb; 142(2):157-63. PubMed ID: 10664524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
    Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine potentiates both basal and GHRH-induced GH secretion in children.
    Bellone J; Farello G; Bartolotta E; Aimaretti G; Bellone S; Mucci M; De Matteis F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):61-4. PubMed ID: 9302373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity.
    Ghigo E; Procopio M; Boffano GM; Arvat E; Valente F; Maccario M; Mazza E; Camanni F
    Metabolism; 1992 May; 41(5):560-3. PubMed ID: 1588839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
    Grottoli S; Procopio M; Maccario M; Zini M; Oleandri SE; Tassone F; Valcavi R; Ghigo E
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
    Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
    Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
    Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
    Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
    Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity?
    Ghigo E; Procopio M; Maccario M; Bellone J; Arvat E; Campana S; Boghen MF; Camanni F
    Horm Metab Res; 1993 Jun; 25(6):305-8. PubMed ID: 8344645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers.
    Broglio F; Benso A; Gottero C; Vito LD; Granata R; Arvat E; Bobbio M; Trevi G; Ghigo E
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):755-8. PubMed ID: 11895217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine.
    Ghigo E; Bellone J; Mazza E; Imperiale E; Procopio M; Valente F; Lala R; De Sanctis C; Camanni F
    Clin Endocrinol (Oxf); 1990 Jun; 32(6):763-7. PubMed ID: 1974484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects.
    Ghigo E; Ceda GP; Valcavi R; Goffi S; Zini M; Mucci M; Valenti G; Cocchi D; Müller EE; Camanni F
    J Endocrinol Invest; 1994 Feb; 17(2):113-7. PubMed ID: 8006330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
    Broglio F; Fubini A; Morello M; Arvat E; Aimaretti G; Gianotti L; Boghen MF; Deghenghi R; Mangiardi L; Ghigo E
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):417-30. PubMed ID: 10468900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
    Broglio F; Benso A; Gottero C; Prodam F; Grottoli S; Tassone F; Maccario M; Casanueva FF; Dieguez C; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):265-71. PubMed ID: 12153607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.